Engel T, Ungar B, Ben-Haim G, Levhar N, Eliakim R, Ben-Horin S
Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
United European Gastroenterol J. 2017 Oct;5(6):880-886. doi: 10.1177/2050640616687838. Epub 2017 Jan 11.
Non-adherence to medication in patients with inflammatory bowel disease (IBD) is a challenging problem which is often overlooked or under-estimated by the physician or denied by the patient. We aimed to examine if re-phrasing the wording of the question used by the physician could help in revealing more patients who are non-adherent, and for whom appropriate counseling may be instituted.
A cross-sectional questionnaire-based study of IBD patients treated in a tertiary center was conducted. Patients received a questionnaire detailing their treatments and disease course, as well as their perceptions about disease. Two forms of questions about adherence were deliberately placed in two separate parts of the questionnaire: One was 'are you taking your medications regularly as prescribed?' (Standard question), and the second, more emphatic question, was 'how often does it happen that you miss a drug dosing?' (Re-phrased question). The rate of non-adherence disclosed by each of these questions was compared. Sensitivity, specificity and predicative values were computed for each question against the conventional definition of non-adherence as taking of less than 80% of prescribed medication doses disclosed by any of the methods. Predictors of non-compliance and of denying non-compliance were also explored.
Overall, 165 patients were included (49% female, mean age 33.7 ± 12.7 SD, median age 30 years, 29.6% with ulcerative colitis, 62.4% with Crohn's disease). Upon questioning, 50 (30.3%) of the patients admitted to non-adherence in the last month when asked by the emphatic re-phrased question format, compared with only 10 patients (6%) reporting non-adherence when asked directly by the standard question (OR 7.4, 95%CI 3.6-15.2, < 0.001). Thus, a 'Do you take your medicine regularly' question format disclosed only 20% of genuinely non-compliant patients and had 16% sensitivity and 98.2% specificity for revealing non-adherence (PPV 80%, NPV 72.9%) compared with the reference re-phrased question. The leading cause for non-adherence was skepticism about drug efficacy or safety (20.5%), followed by vacation or weekend (15%), problems with prescription or pharmacy (13.5%) and forgetfulness (10%). No single demographic or clinical factor correlated with non-adherence. The only factor which correlated with higher probability for non-adherence was biological and combination treatment.
Non-compliance with treatment is much more common than patients admit. Asking patients how often does it happen that they miss a drug dosing is a simple, practical tool which performs significantly better in disclosing non-adherence compared with asking patients if they take their medication as they should.
炎症性肠病(IBD)患者不遵医嘱服药是一个具有挑战性的问题,医生常常忽视或低估这一问题,而患者也往往否认这一问题。我们旨在研究重新措辞医生所使用的问题是否有助于发现更多不遵医嘱服药的患者,以便为他们提供适当的咨询。
对一家三级中心治疗的IBD患者进行了一项基于问卷调查的横断面研究。患者收到一份问卷,详细询问他们的治疗情况、疾病进程以及对疾病的看法。关于依从性的两种问题形式被特意放在问卷的两个不同部分:一个是“你是否按规定定期服药?”(标准问题),另一个更强调的问题是“你漏服药物的情况多久发生一次?”(重新措辞的问题)。比较这两个问题所揭示的不依从率。针对不依从的传统定义(即通过任何方法披露的规定药物剂量服用不足80%),计算每个问题的敏感性、特异性和预测值。还探讨了不依从和否认不依从的预测因素。
总共纳入了165名患者(49%为女性,平均年龄33.7±12.7岁,中位数年龄30岁,29.6%患有溃疡性结肠炎,62.4%患有克罗恩病)。经询问,当以强调性的重新措辞问题形式提问时,50名(30.3%)患者承认在上个月存在不依从情况,而当以标准问题直接询问时,只有10名患者(6%)报告不依从(比值比7.4,95%置信区间3.6 - 15.2,P < 0.001)。因此,与重新措辞的参考问题相比,“你是否定期服药”这种问题形式仅揭示了20%真正不依从的患者,其揭示不依从的敏感性为16%,特异性为98.2%(阳性预测值80%,阴性预测值72.9%)。不依从的主要原因是对药物疗效或安全性的怀疑(20.5%),其次是休假或周末(15%)、处方或药房问题(13.5%)以及遗忘(10%)。没有单一的人口统计学或临床因素与不依从相关。与不依从可能性较高相关的唯一因素是生物制剂和联合治疗。
不遵医嘱治疗的情况比患者承认的要普遍得多。询问患者漏服药物的频率是一种简单实用的工具,与询问患者是否按医嘱服药相比,在揭示不依从方面表现明显更好。